If Gradalis are playing hardball, they may want to give some real thought as to where they go from here in light of Samsung being forced to pay Apple $1B for patent infringements.
I would say the risk factor for them just got a whole lot bigger if they think they can bluff their way through the need for a licence. Certainly, any would-be investor would have to think twice about putting money into Gradalis with the possibility of legal action hanging over them if they try to commercialize a treatment without a licence from BLT.
I think the issue is now definitely just one of timing. They may be waiting until they have more cash in the bank before taking out a licence so as not to divert R&D funds at this stage of development. Who knows, but I think giving them a little nudge right now, after the pro Apple judgement, would not go astray.
- Forums
- ASX - By Stock
- BLT
- gradalis playing hardball or business as usual
gradalis playing hardball or business as usual, page-38
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online